An artificially constructed radiation-responsive promoter is activated by doxorubicin.

Saved in:
Bibliographic Details
Title: An artificially constructed radiation-responsive promoter is activated by doxorubicin.
Authors: Ogawa R; Department of Radiological Sciences, Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama, Toyama, Japan. ogawa@med.u-toyama.ac.jp, Morii A, Watanabe A, Cui ZG, Kagiya G, Doi N, Zhao QL, Feril LB Jr
Source: Cancer gene therapy [Cancer Gene Ther] 2012 May; Vol. 19 (5), pp. 345-51. Date of Electronic Publication: 2012 Mar 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5500 (Electronic) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5500
DOI:10.1038/cgt.2012.7